Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kohei Horimoto

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Frontiers in Medicine|September 10, 2019
Dermoscopy of Melanoma and Non-melanoma Skin CancersJunji Kato, Kohei Horimoto, Sayuri Sato, et al.
Journal of Skin Cancer|December 15, 2010
A Case of Cystic Basal Cell Carcinoma Which Shows a Homogenous Blue/Black Area under DermatoscopyAkihiro Yoneta, Kohei Horimoto, Keiko Nakahashi, et al.
The Journal of Dermatology|August 1, 2020
Usefulness of neuron-specific enolase as a serum marker of metastatic melanomaSayuri Sato, Junji Kato, Masahide Sawada, et al.
The Journal of Dermatology|November 9, 2017
Imiquimod 5% cream as a therapeutic option for extramammary Paget's diseaseMasahide Sawada, Junji Kato, Toshiharu Yamashita, et al.
The Journal of Dermatology|October 26, 2024
Extramammary Paget's disease treated with of anti-programmed cell death protein 1 therapy after docetaxel therapy failureMidori Narasaki, Junji Kato, Sayuri Sato, et al.
International Journal of Clinical Oncology|June 1, 2022
Difference in immunohistochemical findings among anti-PD-L1 antibodies and their relationships with CD4+ and CD8+ T cells in Japanese melanoma patientsDaisuke Yoneta, Junji Kato, Takafumi Kamiya, et al.
The Journal of Dermatology|December 14, 2017
Dermoscopic features distinctive for extraocular sebaceous carcinomaKohei Horimoto, Junji Kato, Yasuyuki Sumikawa, et al.
The Journal of Dermatology|February 3, 2017
Serum cytokeratin 19 fragment 21-1 is a useful tumor marker for the assessment of extramammary Paget's diseaseJunji Kato, Yasuyuki Sumikawa, Tokimasa Hida, et al.
The Journal of Dermatology|September 12, 2017
Successful TS-1 monotherapy as the second-line treatment for advanced extramammary Paget's disease: A report of two casesJunji Kato, Tokimasa Hida, Toshiharu Yamashita, et al.
Cancer Medicine|November 20, 2024
Genetic Characteristics of Cutaneous, Acral, and Mucosal Melanoma in JapanTokimasa Hida, Masashi Idogawa, Junji Kato, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Frontiers in Medicine|September 10, 2019
Dermoscopy of Melanoma and Non-melanoma Skin CancersJunji Kato, Kohei Horimoto, Sayuri Sato, et al.
Journal of Skin Cancer|December 15, 2010
A Case of Cystic Basal Cell Carcinoma Which Shows a Homogenous Blue/Black Area under DermatoscopyAkihiro Yoneta, Kohei Horimoto, Keiko Nakahashi, et al.
The Journal of Dermatology|August 1, 2020
Usefulness of neuron-specific enolase as a serum marker of metastatic melanomaSayuri Sato, Junji Kato, Masahide Sawada, et al.
The Journal of Dermatology|November 9, 2017
Imiquimod 5% cream as a therapeutic option for extramammary Paget's diseaseMasahide Sawada, Junji Kato, Toshiharu Yamashita, et al.
The Journal of Dermatology|October 26, 2024
Extramammary Paget's disease treated with of anti-programmed cell death protein 1 therapy after docetaxel therapy failureMidori Narasaki, Junji Kato, Sayuri Sato, et al.
International Journal of Clinical Oncology|June 1, 2022
Difference in immunohistochemical findings among anti-PD-L1 antibodies and their relationships with CD4+ and CD8+ T cells in Japanese melanoma patientsDaisuke Yoneta, Junji Kato, Takafumi Kamiya, et al.
The Journal of Dermatology|December 14, 2017
Dermoscopic features distinctive for extraocular sebaceous carcinomaKohei Horimoto, Junji Kato, Yasuyuki Sumikawa, et al.
The Journal of Dermatology|February 3, 2017
Serum cytokeratin 19 fragment 21-1 is a useful tumor marker for the assessment of extramammary Paget's diseaseJunji Kato, Yasuyuki Sumikawa, Tokimasa Hida, et al.
The Journal of Dermatology|September 12, 2017
Successful TS-1 monotherapy as the second-line treatment for advanced extramammary Paget's disease: A report of two casesJunji Kato, Tokimasa Hida, Toshiharu Yamashita, et al.
Cancer Medicine|November 20, 2024
Genetic Characteristics of Cutaneous, Acral, and Mucosal Melanoma in JapanTokimasa Hida, Masashi Idogawa, Junji Kato, et al.
Pageof 2